Catheter Precision (VTAK) Income from Continuing Operations (2017 - 2026)
Catheter Precision's (VTAK) quarterly Income from Continuing Operations came in at 1690000.0 in Q1 2026, up 58.22% year-on-year from 1068132.81 in Q1 2025, and down 356.76% on a QoQ basis from 370000.0 in Q4 2025.
Catheter Precision (VTAK) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Catheter Precision (VTAK) has 10 years of Income from Continuing Operations data on file, last reported at 1690000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 58.22% year-over-year to 1690000.0 in Q1 2026; TTM through Mar 2026 was 10656000.0, a 28.35% increase from a year earlier, with the FY2025 full-year figure at 15409000.0, down 14.12% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 1690000.0, down from 370000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for VTAK reached as high as 370000.0 in Q4 2025 and fell as low as 66400000.0 in Q1 2023.
- Historically, Income from Continuing Operations has averaged 7390588.24 across 5 years, with a median of 4045000.0 in 2025.
- Across the five-year window, Income from Continuing Operations tumbled 1108.37% in 2023 and jumped 95.97% in 2024, its largest moves.
- Year by year, Income from Continuing Operations stood at 8159000.0 in 2022, then surged by 91.8% to 669000.0 in 2023, then plunged by 271.75% to 2487000.0 in 2024, then surged by 85.12% to 370000.0 in 2025, then slumped by 356.76% to 1690000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 1690000.0 in Q1 2026, 370000.0 in Q4 2025, and 2188000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Catheter Precision | 0.80 | -811,999.20 | 390,000.00 | -1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.69 Mn |
| Dec 31, 2025 | -370,000.00 |
| Sep 30, 2025 | -2.19 Mn |
| Jun 30, 2025 | -6.41 Mn |
| Mar 31, 2025 | -4.05 Mn |
| Dec 31, 2024 | -2.49 Mn |
| Sep 30, 2024 | -4.12 Mn |
| Jun 30, 2024 | -4.22 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Dec 31, 2023 | -669,000.00 |
| Sep 30, 2023 | -1.93 Mn |
| Jun 30, 2023 | -1.58 Mn |
| Mar 31, 2023 | -66.40 Mn |
| Dec 31, 2022 | -8.16 Mn |
| Sep 30, 2022 | -4.76 Mn |
| Jun 30, 2022 | -8.45 Mn |
| Mar 31, 2022 | -5.50 Mn |
| Dec 31, 2021 | -8.28 Mn |
| Sep 30, 2021 | -7.38 Mn |
| Jun 30, 2021 | -5.25 Mn |